Popat, R., K. Uttervall, K.M. Kortüm, H. Magen, M. Hansson, T. Shragai, E. Terpos, C. T. Hansen, S. Manier, H. Gregersen, Ø.M. Ottestad, C. Touzeau, E. Hatjiharissi, S.L. Farmer, E. Katodritou, E. Spanoudakis, M.Ø. Vase, C. Liberatore, M. Papathanasiou, M.K. Angelopoulou, E. Clavero, R. Kittus, P. Smirnov, P. Hu, D. Santra, C. Albrecht, E. Rubio-Azpeitia, and A. Perrot. 2026. “P41 | FIRST RESULTS OF REALiTEC-2: SECOND COHORT OF REALiTEC, AN INTERNATIONAL OBSERVATIONAL RETROSPECTIVE STUDY OF TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN ROUTINE CLINICAL PRACTICE”. Haematologica 111 (s2). Pavia, Italy. https://doi.org/10.3324/haematol.2026.s2.14038.